Heard on a podcast
OpenAI targets $1.4 trillion valuation with biotech-focused expansion
OpenAI is closing a $30 billion funding round and acquiring Orchestra Bio to integrate specialized agents into its GPT-Rosalind model.

The AI Daily Brief: Artificial Intelligence News and Analysis ·